Lv32
290 积分 2021-09-01 加入
Current research topics in FAPI theranostics: a bibliometric analysis
7小时前
已完结
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
23小时前
已完结
Decoding tumors from fibroblast activation protein: A review of the latest diagnostic and therapeutic prospects
23小时前
已完结
Fibroblast Activation Protein-Targeted Theranostics: Current Status in Clinical Development
1天前
已完结
A new radioactive microsphere: Y-90 carbon microsphere for selective internal radiation therapy of advanced liver cancer
1天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
9天前
已完结
Effect of Targeting apoC-III with Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
9天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
9天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
9天前
已完结
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia
9天前
已完结
皖公网安备34019202002308
